Mr. Steve Loutskou reports

RESTART LIFE SCIENCES REPORTS SECOND QUARTER 2026 RESULTS HIGHLIGHTED BY 146% SEQUENTIAL REVENUE GROWTH

Restart Life Sciences Corp. has released its financial and operating results for the three and six months ended June 30, 2026. All financial figures are expressed in Canadian dollars ($) unless otherwise noted, are prepared in accordance with international financial reporting standards (IFRS), and are unaudited.

In the second quarter of 2026, Restart Life Sciences continued its operational transition following the acquisition of 100 per cent of Holy Crap Foods Inc. on Feb. 26, 2026, shifting from a non-revenue issuer to a revenue-producing consumer packaged goods (CPG) business. The company recorded quarter-over-quarter revenue growth and maintained its product margins across its sales channels.

Q2 2026 and H1 2026 financial highlights

• Initial revenue generation: Total revenue for the six months ended June 30, 2026 (H1 2026), was $465,715, compared with nil in the prior-year period (H1 2025).
• Quarter-over-quarter revenue: Revenue for the three months ended June 30, 2026 (Q2 2026), was $331,162. This represents a 146-per-cent sequential increase over Q1 2026, reflecting the continuing integration of Holy Crap's operations.
• Brand performance: Holy Crap generated approximately $110,000 in revenue in June, 2026, with approximately 35-per-cent gross margins. This represents a 64.2-per-cent year-over-year increase for the brand, supported by sales across its wholesale, distribution and e-commerce channels.
• Gross margins: Q2 2026 gross profit was $130,699, representing a 39.5-per-cent gross margin. For the first half of the year, gross profit was $192,636, achieving an overall 41.4-per-cent gross margin.
• Balance sheet updates: The company's total asset base was $1,903,647 as at June 30, 2026 (up from $1,767,208 at Dec. 31, 2025). Shareholders' equity was $1,324,748.

"Our management team remains focused on strategic growth, revenue generation and market expansion," stated Steve Loutskou, chief executive officer of Restart Life. "Transitioning from a non-revenue issuer a year ago to reporting $465,715 in revenue for the first half of 2026 reflects the initial integration of our operations. With our presence on digital platforms, our entry into the U.S. market via Amazon and our evaluation of potential M&A opportunities, we continue to execute our business plan, though we recognize the ongoing costs, capital requirements and operational risks necessary to scale the business over the long term."

During the period and subsequent to the quarter-end, the company advanced several operational initiatives:

• Walmart Canada listing: On April 28, 2026, the company announced that Holy Crap secured a listing on Walmart Canada's on-line marketplace, Walmart.ca. The initial product lineup has been accepted, exposing the brand to new Canadian consumers.
• United States and international pilot: On May 13, 2026, the company announced its entry into the U.S. market through Amazon USA. Furthermore, on June 10, 2026, the company launched a multimonth market pilot in the Caribbean via a local on-demand delivery platform to evaluate international demand.
• Product development: As previously announced on March 3, 2026, and April 30, 2026, following a collaboration with the University of Manitoba's Richardson Centre for Food Technology and Research (RCFTR), the company has commenced commercial production of a new protein-focused product line. The company also continues to develop specific formulations targeting youth and senior consumer segments.
• Digital integration: The company is integrating artificial-intelligence-driven tools and customer relationship management platforms to support online sales, customer engagement and operational efficiency.
• M&A (merger and acquisition) evaluation: Utilizing its operational manufacturing facility, management continues to evaluate targeted merger and acquisition opportunities within the health and CPG (consumer packaged goods) sectors. The company is focused on established, revenue-generating businesses that align with its existing infrastructure. While the goal of these evaluations is to support future revenue growth, any potential acquisitions are subject to capital availability, integration risks and standard closing conditions. There can be no assurance that these efforts will result in completed transactions or anticipated financial growth.

About Restart Life Sciences Corp.

Restart Life Sciences is a Canadian-based life sciences company listed on the CSE.

About Holy Crap Foods Inc.

Holy Crap Superseed Cereal and Holy Crap Superseed Oatmeal are premium functional food brands offering nutrient-dense, clean-label products made with simple, high-quality ingredients. Based in Gibsons, B.C., the brand has built a loyal and growing customer base across Canada, driven by strong consumer trust and repeat purchases.

Positioned within the fast-growing gut health and wellness category, Holy Crap's gluten-free, non-GMO (genetically modified organism), high-fibre products support digestive health and sustained energy, while gaining traction as a trusted, everyday solution for health-conscious consumers.

We seek Safe Harbor.